SAR-442257
SAR442257 is a humanized IgG4-S228P, kappa monoclonal antibody targeting CD38 and CD28 on multiple myeloma cells and co-stimulates CD3 and CD28 on T cells[1].
Product Specifications
UNSPSC
12352203
Target
CD28; CD3; CD38
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
99.0
Smiles
[*]S[R442257]
Molecular Weight
(145.44 kDa)
References & Citations
[1]Grab AL, et al. Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple Myeloma. Cells. 2024 May 20;13 (10) :879.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
130615-Biotin 100 µL
Nucleobindin 1 (NUCB1, CALNUC, NUC, FLJ40471) (Biotin)
Sign In for Pricing
View Details 
B0003-47N-HRP 200 µL
Bad, phosphorylated (Ser75) (Bcl2 Antagonist Of Cell Death, BAD, Bcl-2-binding Component 6, Bcl-XL/Bcl-2-Associated Death Promoter, Bcl-2-like 8 Protein, BAD, BBC6, BCL2L8) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details